Search Results 191-200 of 436 for ❣베스트토토검증【평생베스트.com】베스트토토❣

  1. Phase 3 Study to Treat Patients with Soft Tissue Sarcomas - Mayo Clinic

    ... best. Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  2. Semen Analysis in Chemotherapy - Clinical Trials

    ... best. Study IDs. Site IRB. Rochester, Minnesota: 16-010649. Sponsor Protocol Number: 16-010649. About this study. The purpose of this study is to correlate the ...

  3. Publications

    Publications. Shanafelt TD, West CP, Sinsky C, Trockel M, Tutty M, Wang H, Carlasare LE, Dyrbye LN. Changes in Burnout and Satisfaction With Work-Life ...

  4. Impact of Estradiol Addback - Mayo Clinic

    ... best. Study phase. 1. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  5. Heart Disease Clinical Trials - Mayo Clinic Research

    ... best management strategy compared with an initial conservative strategy of optimal medical therapy alone for higher-risk patients with stable ischemic heart ...

  6. A Study to Evaluate Whether Macitentan is an Effective and Safe Treatment for Patients With Heart Failure With Preserved Ejection Fraction and Pulmonary Vascular Disease - Mayo Clinic

    ... best. Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  7. Heart disease in women: Understand symptoms and risk factors - Mayo Clinic

    Ask your healthcare team what weight is best for you. Manage stress. Stress can cause the arteries to get tight. This can increase the risk of heart disease ...

  8. A Study of Tazemetostat in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Endometrial Cancer - Mayo Clinic

    ... best. Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  9. Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) - Mayo Clinic

    ... best. Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later ...

  10. A Clinical Trial to Evaluate the HeartWare Ventricular Assist System (ENDURANCE SUPPLEMENTAL TRIAL) - Mayo Clinic

    ... best. Study IDs. Site IRB. Rochester, Minnesota: 13-006972. NCT ID: NCT01966458. Sponsor Protocol Number: HW004-A Ver. 3.0. About this study. This is a ...